The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer.
Huaifeng LiYunpeng JinYunping HuLin JiangFatao LiuYijian ZhangYajuan HaoShili ChenXiangsong WuYing-Bin LiuPublished in: Cancer science (2018)
Gallbladder cancer (GBC) is the most common malignant tumor of the biliary tract system. Epithelial-mesenchymal transition (EMT) plays a vital role in the process of tumor metastasis. Mesenchymal-like cells can serve as a source of cancer stem cells, which can confer the EMT phenotype. Placental growth factor (PLGF) belongs to the vascular endothelial growth factor family and plays a vital role in cancer. However, the underlying molecular mechanisms about the influence of PLGF on EMT in GBC remain unknown. Here we show that PLGF expression levels were higher in GBC tissues than in normal adjacent tissues and were associated with poor prognosis in GBC patients. Exogenous PLGF enhanced the migration, invasion, and tumorsphere formation of GBC cells. Conversely, knockdown of PLGF decreased the aggressive phenotype of GBC cells. Mechanistically, exogenous PLGF upregulated microRNA-19a (miR-19a) expression through the activation of c-MYC. Moreover, Spearman's correlation analysis showed a positive pairwise correlation among PLGF, c-MYC, and miR-19a expression in GBC tissues. Taken together, these results suggest that PLGF promotes EMT and tumorsphere formation through inducing miR-19a expression by upregulating c-MYC. Thus, PLGF could be a promising molecular therapeutic target for GBC.
Keyphrases
- poor prognosis
- long non coding rna
- epithelial mesenchymal transition
- cell proliferation
- papillary thyroid
- growth factor
- vascular endothelial growth factor
- induced apoptosis
- transforming growth factor
- long noncoding rna
- stem cells
- cancer stem cells
- squamous cell
- binding protein
- newly diagnosed
- oxidative stress
- endoplasmic reticulum stress
- prognostic factors
- bone marrow
- endothelial cells
- young adults
- lymph node metastasis
- single molecule
- patient reported outcomes
- childhood cancer